Lastly, although we conducted immunohistochemical staining experiments in vivo to verify the role of Fabp5 in AP, the mechanisms underlying how hypercholesterolemia affects the expression of Fabp5 and how Fabp5 exacerbates the severity of AP have not been validated in vivo and in vitro. Here, FABP5 is linked to Hypercholesterolemia.